{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:13:25Z","timestamp":1794496405139,"version":"4.9.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Institute of Arthritis"},{"name":"Musculoskeletal and Skin Diseases","award":["K23 AR069688"],"award-info":[{"award-number":["K23 AR069688"]}]},{"name":"Musculoskeletal and Skin Diseases","award":["R03 AR075886"],"award-info":[{"award-number":["R03 AR075886"]}]},{"name":"Musculoskeletal and Skin Diseases","award":["L30 AR066953"],"award-info":[{"award-number":["L30 AR066953"]}]},{"name":"Musculoskeletal and Skin Diseases","award":["P30 AR070253"],"award-info":[{"award-number":["P30 AR070253"]}]},{"name":"Musculoskeletal and Skin Diseases","award":["P30 AR072577"],"award-info":[{"award-number":["P30 AR072577"]}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008552","name":"Brigham Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008552","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R. Bruce and Joan M. Mickey Research Scholar Fund"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL119558"],"award-info":[{"award-number":["K23 HL119558"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R03 HL148484"],"award-info":[{"award-number":["R03 HL148484"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["IM101-763"],"award-info":[{"award-number":["IM101-763"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to investigate the prevalence, incidence and cause-specific mortality of RA-associated interstitial lung disease (RA-ILD) among older US patients with RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a nationwide cohort study using Medicare claims data (parts A, B and D for 2008\u20132017). RA was identified with a validated algorithm using RA diagnosis codes and DMARD prescription. RA-ILD was identified with a validated algorithm using ILD diagnosis codes by a rheumatologist\/pulmonologist. RA-ILD was categorized as prevalent or incident relative to the initial RA observation (baseline\/index date). We compared the total mortality of RA-ILD to RA without ILD using multivariable Cox regression, adjusting for baseline covariates. For cause-specific mortality, Fine and Gray subdistribution hazard ratios (sdHRs) were estimated to handle competing risks of alternative mortality causes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 509\u00a0787 RA patients (mean age 72.6\u2009years, 76.2% female), 10\u00a0306 (2.0%) had prevalent RA-ILD at baseline. After baseline, 13\u00a0372 (2.6%) developed RA-ILD during 1\u00a0873\u00a0127 person-years of follow-up (median 3.0\u2009years\/person). During follow-up, 38.7% of RA-ILD patients died compared with 20.7% of RA patients without ILD. After multivariable adjustment, RA-ILD had an HR of 1.66 (95% CI 1.60, 1.72) for total mortality. Accounting for competing risk of other causes of death, RA-ILD had an sdHR of 4.39 (95% CI 4.13, 4.67) for respiratory mortality and an sdHR of 1.56 (95% CI 1.43, 1.71) for cancer mortality compared with RA without ILD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>RA-ILD was present or developed in nearly 5% of patients in this nationwide study of older patients with RA. Compared with RA without ILD, RA-ILD was associated with excess total, respiratory and cancer mortality that was not explained by measured factors.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa836","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T03:26:55Z","timestamp":1605842815000},"page":"3689-3698","source":"Crossref","is-referenced-by-count":93,"title":["Prevalence, incidence and cause-specific mortality of rheumatoid arthritis\u2013associated interstitial lung disease among older rheumatoid arthritis patients"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4618","authenticated-orcid":false,"given":"Jeffrey A","family":"Sparks","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Inflammation, and Immunity, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Harvard Medical School, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1397-3106","authenticated-orcid":false,"given":"Yinzhu","family":"Jin","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Kyung","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seanna","family":"Vine","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Desai","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy J","family":"Doyle","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Division of Pulmonary and Critical Care Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-3579","authenticated-orcid":false,"given":"Seoyoung C","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Inflammation, and Immunity, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Harvard Medical School, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"2021080220003558800_keaa836-B1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/acr.22642","article-title":"Cause-specific mortality in male US veterans with rheumatoid arthritis","volume":"68","author":"England","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2021080220003558800_keaa836-B2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/acr.22752","article-title":"Rheumatoid arthritis and mortality among women during 36 years of prospective follow-up: results from the Nurses' Health Study","volume":"68","author":"Sparks","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2021080220003558800_keaa836-B3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995\u20132007 versus 1985\u20131994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"key":"2021080220003558800_keaa836-B4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021080220003558800_keaa836-B5","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021080220003558800_keaa836-B6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00296-017-3781-7","article-title":"Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis","volume":"37","author":"Kim","year":"2017","journal-title":"Rheumatol Int"},{"key":"2021080220003558800_keaa836-B7","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","article-title":"The lung in a cohort of rheumatoid arthritis patients\u2014an overview of different types of involvement and treatment","volume":"58","author":"Duarte","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021080220003558800_keaa836-B8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1378\/chest.13-1394","article-title":"Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis","volume":"146","author":"Doyle","year":"2014","journal-title":"Chest"},{"key":"2021080220003558800_keaa836-B9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol"},{"key":"2021080220003558800_keaa836-B10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis\u2013interstitial lung disease\u2013associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2021080220003558800_keaa836-B11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40674-020-00160-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: current update on prevalence, risk factors, and pharmacologic treatment","volume":"6","author":"Huang","year":"2020","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"2021080220003558800_keaa836-B12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurjrheum.2019.19044","article-title":"Interstitial lung abnormalities in patients with early rheumatoid arthritis: a pilot study evaluating prevalence and progression","volume":"6","author":"Dong","year":"2019","journal-title":"Eur J Rheumatol"},{"key":"2021080220003558800_keaa836-B13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2021080220003558800_keaa836-B14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","article-title":"Pulmonary involvement in early rheumatoid arthritis patients","volume":"30","author":"Habib","year":"2011","journal-title":"Clin Rheumatol"},{"key":"2021080220003558800_keaa836-B15","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2021080220003558800_keaa836-B16","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2021080220003558800_keaa836-B17","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2021080220003558800_keaa836-B18","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","article-title":"Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities","volume":"39","author":"Saag","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2021080220003558800_keaa836-B19","doi-asserted-by":"crossref","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"2021080220003558800_keaa836-B20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.semarthrit.2020.04.006","article-title":"Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis","volume":"50","author":"Cho","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2021080220003558800_keaa836-B21","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar3260","article-title":"Validation of rheumatoid arthritis diagnoses in health care utilization data","volume":"13","author":"Kim","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021080220003558800_keaa836-B22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2021080220003558800_keaa836-B23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/pds.3953","article-title":"Identification of smoking using Medicare data\u2013a validation study of claims-based algorithms","volume":"25","author":"Desai","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021080220003558800_keaa836-B24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2021080220003558800_keaa836-B25","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021080220003558800_keaa836-B26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021080220003558800_keaa836-B27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/art.41194","article-title":"Asthma, chronic obstructive pulmonary disease, and subsequent risk for incident rheumatoid arthritis among women: a prospective cohort study","volume":"72","author":"Ford","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021080220003558800_keaa836-B28","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/art.41452","article-title":"Pulmonary adverse events of low-dose methotrexate in the randomized double-blind placebo-controlled Cardiovascular Inflammation Reduction Trial","volume":"72","author":"Sparks","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021080220003558800_keaa836-B29","article-title":"Methotrexate and rheumatoid arthritis associated interstitial lung disease","author":"Juge","year":"2020","journal-title":"Eur Respir J"},{"key":"2021080220003558800_keaa836-B30","article-title":"The associations of interstitial lung abnormalities with cancer diagnoses and mortality","volume":"56","author":"Axelsson","year":"2020","journal-title":"Eur Respir J"},{"key":"2021080220003558800_keaa836-B31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4143\/crt.2017.119","article-title":"Interstitial lung disease and lung cancer development: a 5-year nationwide population-based study","volume":"50","author":"Choi","year":"2018","journal-title":"Cancer Res Treat"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/8\/3689\/39543495\/keaa836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/8\/3689\/39543495\/keaa836.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T20:14:45Z","timestamp":1627935285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/8\/3689\/6104048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,1,18]]},"published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa836","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,1,18]]}}}